John Hiserodt, MD
Pathologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Effusions Pleural Mesothelioma Pleural Plaques Pleuritis Testicular Mesothelioma
Cancer Antigen 125, CA Fibulin-3 Human MPF ELISA Kit Mesomark Osteopontin SOMAmer Panel
Dr. Hiserodt graduated the medical school from the David Geffen School of Medicine at UCLA and completed his residency program at the University of Michigan Hospitals and Health Center. A fellowship followed at the Allegheny County Coroner's Office soon after that. He is specialized in Pathology and board certified in Pathology. Dr. Hiserodt has been in practice for more than 20 years and during his career, he has also contributed to various publications of medical interest.
David Geffen School of Medicine at UCLA
Medical School
University of Michigan Hospitals and Health Centers
Residency
Allegheny County Coroner's Office
Fellowship
American Board of Pathology
Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage colony-st...
Graf, M. R., Jadus, M. R., Hiserodt, J. C., Wepsic, H. T., Granger, G. A.; J Immunol. 1999 Nov 15.
See more >>Expression of surface antigens during the differentiation of human dendritic cells vs macrophages from blood monocytes in vitro.
Santin, A. D., Hermonat, P. L., Ravaggi, A., Chiriva-Internati, M., Cannon, M. J., Hiserodt, J. C., Pecorelli, S., Parham, G. P.; Immunobiology. 1999 Jun.
See more >>Effects of retinoic acid combined with irradiation on the expression of major histocompatibility complex molecules and adhesion/costimulation molecules ICAM-1 in human...
Santin, A. D., Hermonat, P. L., Ravaggi, A., Chiriva-Internati, M., Hiserodt, J. C., Pecorelli, S., Parham, G. P.; Gynecol Oncol. 1998 Aug.
See more >>